New research reveals 25% tariffs on Canadian pharmaceuticals would impact critical medications, strain supply chains, and potentially increase costs—with 28 drugs having no alternative suppliers.
A study finds that total hip arthroplasty in patients with minimal radiographic osteoarthritis results in high satisfaction but lower functional outcomes, with only 33% achieving a patient-acceptable symptom state.
Omega-3 supplementation has shown potential in reducing inflammation and improving symptoms in osteoarthritis, though further research is needed to confirm its efficacy.
Explore the FDA's proposed changes for biosimilar drugs and their interchangeability, including expert insights on regulatory impacts and market dynamics.
NIH director, Dr. Monica M. Bertagnolli, is stepping down after launching major initiatives in women's health and long COVID research, indicating optimism for their continuation under new leadership.